Sunesis Pharmaceuticals (SNSS) Misses Q1 EPS by 12c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
License and other revenue: 610K
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
License and other revenue: 610K
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q1 EPS of ($0.30), $0.12 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $0 versus the consensus estimate of $90 thousand.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- International Petroleum Corporation Announces Results of Normal Course Issuer Bid
- International Petroleum Corporation Announces Results of Normal Course Issuer Bid
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
